The Prevalence of Concomitant Skip Small Bowel Lesions in Crohn’s Disease and Their Effects on Reoperation in Patients Undergoing Ileocolic Resection

[1]  J. Leighton,et al.  Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease Patients. , 2021, Inflammatory bowel diseases.

[2]  S. Travis,et al.  Does Smoking Cessation Reduce Surgical Recurrence After Primary Ileocolic Resection for Crohn’s Disease? , 2019, Diseases of the colon and rectum.

[3]  E. Vicaut,et al.  Penetrating Crohn Disease Is Not Associated With a Higher Risk of Recurrence After Surgery: A Prospective Nationwide Cohort Conducted by the Getaid Chirurgie Group. , 2019, Annals of surgery.

[4]  W. Koltun,et al.  Clinical and Genetic Factors Impact Time to Surgical Recurrence After Ileocolectomy for Crohn's Disease , 2019, Annals of surgery.

[5]  Eun Soo Kim,et al.  Risk Factors for Postoperative Recurrence in Korean Patients with Crohn’s Disease , 2019, Gut and liver.

[6]  G. Kaplan,et al.  Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study , 2019, Gut.

[7]  W. Bemelman Evolving Role of IBD Surgery. , 2018, Journal of Crohn's & colitis.

[8]  M. Regueiro,et al.  ACG Clinical Guideline: Management of Crohn’s Disease in Adults , 2018, The American Journal of Gastroenterology.

[9]  T. Shimosegawa,et al.  Residual Lesions on Capsule Endoscopy Is Associated with Postoperative Clinical Recurrence in Patients with Crohn’s Disease , 2018, Digestive Diseases and Sciences.

[10]  E. Vicaut,et al.  DOP037 Postoperative anti-TNF therapy is associated with a significant reduction of both endoscopic and clinical recurrence following surgery for ileocolonic Crohn’s disease: results of a prospective nationwide cohort conducted by the GETAID chirurgie group , 2018 .

[11]  A. Cheifetz,et al.  Crohn Disease: Epidemiology, Diagnosis, and Management , 2017, Mayo Clinic proceedings.

[12]  C. Buskens,et al.  ECCO-ESCP Consensus on Surgery for Crohn's Disease. , 2017, Journal of Crohn's & colitis.

[13]  C. Buskens,et al.  3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. , 2017, Journal of Crohn's & colitis.

[14]  J. Zhong,et al.  Potential model for differential diagnosis between Crohn's disease and primary intestinal lymphoma , 2016, World journal of gastroenterology.

[15]  M. Regueiro,et al.  Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection. , 2016, Gastroenterology.

[16]  Subrata Ghosh,et al.  Cumulative Incidence of Second Intestinal Resection in Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Studies , 2014, The American Journal of Gastroenterology.

[17]  F. Michelassi,et al.  Surgical Treatment of Complex Small Bowel Crohn Disease , 2014, Annals of surgery.

[18]  M. Mittlböck,et al.  Surgical recurrence after primary ileocolic resection for Crohn’s disease , 2014, Techniques in Coloproctology.

[19]  E. Savarino,et al.  Adalimumab Is More Effective Than Azathioprine and Mesalamine at Preventing Postoperative Recurrence of Crohn's Disease: A Randomized Controlled Trial , 2013, The American Journal of Gastroenterology.

[20]  Jia Ju Zheng,et al.  Prevalence and incidence rates of Crohn's disease in mainland China: A meta‐analysis of 55 years of research , 2010, Journal of digestive diseases.

[21]  W. Reinisch,et al.  The Impact of Thiopurines on the Risk of Surgical Recurrence in Patients With Crohn's Disease After First Intestinal Surgery , 2010, The American Journal of Gastroenterology.

[22]  M. Regueiro,et al.  Infliximab prevents Crohn's disease recurrence after ileal resection. , 2009, Gastroenterology.

[23]  Yan Yan,et al.  Risk Factors for Surgical Recurrence after Ileocolic Resection of Crohn’s Disease , 2008, Diseases of the colon and rectum.

[24]  A. Darzi,et al.  A Meta-Analysis Comparing Incidence of Recurrence and Indication for Reoperation After Surgery for Perforating Versus Nonperforating Crohn's Disease , 2008, The American Journal of Gastroenterology.

[25]  J. Satsangi,et al.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.

[26]  Takayuki Yamamoto Factors affecting recurrence after surgery for Crohn's disease. , 2005, World journal of gastroenterology.

[27]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[28]  S. Hanauer,et al.  Management of Crohn's Disease in Adults , 2001, The American Journal of Gastroenterology.

[29]  G. Hellers,et al.  Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease , 2000, The British journal of surgery.

[30]  H. Schumacher,et al.  The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease. , 1996, Annals of surgery.

[31]  P. Desreumaux,et al.  Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease. , 1995, The American journal of gastroenterology.

[32]  T. Balestracci,et al.  Primary and recurrent Crohn's disease. Experience with 1379 patients. , 1991, Annals of surgery.

[33]  A. Peña,et al.  Crohn's disease: risk of recurrence and reoperation in a defined population. , 1989, Gut.

[34]  H. Tilg,et al.  3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management , 2017, Journal of Crohn's & colitis.

[35]  T. Raffin,et al.  Epidemiology, Diagnosis, and Management , 2015 .

[36]  Subrata Ghosh,et al.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.